Eijkemans M J C, Kersten F A M, Lintsen A M E, Hunault C C, Bouwmans C A M, Roijen L Hakkaart-van, Habbema J D F, Braat D D M
Department of Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Department of Public Health, Erasmus MC, University Medical Center, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands.
Hum Reprod. 2017 May 1;32(5):999-1008. doi: 10.1093/humrep/dex018.
How does the cost-effectiveness (CE) of immediate IVF compared with postponing IVF for 1 year, depend on prognostic characteristics of the couple?
The CE ratio, i.e. the incremental costs of immediate versus delayed IVF per extra live birth, is the highest (range of €15 000 to >€60 000) for couples with unexplained infertility and for them depends strongly on female age and the duration of infertility, whilst being lowest for endometriosis (range 8000-23 000) and, for such patients, only slightly dependent on female age and duration of infertility.
A few countries have guidelines for indications of IVF, using the diagnostic category, female age and duration of infertility. The CE of these guidelines is unknown and the evidence base exists only for bilateral tubal occlusion, not for the other diagnostic categories.
STUDY DESIGN, SIZE, DURATION: A modelling approach was applied, based on the literature and data from a prospective cohort study among couples eligible for IVF or ICSI treatment, registered in a national waiting list in The Netherlands between January 2002 and December 2003.
PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 5962 couples was included. Chances of natural ongoing pregnancy were estimated from the waiting list observations and chances of ongoing pregnancy after IVF from follow-up data of couples with primary infertility that began treatment. Prognostic characteristics considered were female age, duration of infertility and diagnostic category. Costs of IVF were assessed from a societal perspective and determined on a representative sample of patients. A cost-effectiveness comparison was made between two scenarios: (I) wait one more year and then undergo IVF for 1 year and (II) immediate IVF during 1 year, and try to conceive naturally in the following year. Comparisons were made for strata determined by the prognostic factors. The final outcome was a live birth.
The gain in live birth rate of the immediate IVF scenario versus postponed IVF increased with female age, and was independent from diagnostic category or duration of infertility. By contrast, the corresponding increase in costs primarily depended on diagnostic category and duration of infertility. The lowest CE ratio was just below €10 000 per live birth for endometriosis from age 34 onwards at 1 year duration. The highest CE ratio reached €56 000 per live birth for unexplained infertility at age 30 and 3 years duration, dropping to values below € 30 000 per live birth from age 32 onwards. It reached values below €20 000 per live birth with 3 years duration at age 34 and older. The CE ratio was in between for the three other diagnostic categories (i.e. Male infertility, Hormonal and Immunological/Cervical).
LIMITATIONS, REASONS FOR CAUTION: We applied estimates of chances with IVF, excluding frozen embryos, for which we had no data. Therefore, we do not know the effect of frozen embryo transfers on the CE.
The duration of infertility at which IVF becomes cost-effective depends, firstly, on the level of society's willingness to pay for one extra live birth, and secondly, given a certain level of willingness to pay, on the woman's age and the diagnostic category. In current guidelines, the chances of a natural conception should always be taken into account before deciding whether to start IVF treatment and at which time.
STUDY FUNDING/COMPETING INTEREST(S): Supported by Netherlands Organisation for Health Research and Development (ZonMW, grant 945-12-013). ZonMW had no role in designing the study, data collection, analysis and interpretation of data or writing of the report. Competing interests: none.
与将体外受精(IVF)推迟1年相比,立即进行IVF的成本效益(CE)如何取决于夫妇的预后特征?
CE比率,即每多一个活产儿,立即进行IVF与延迟进行IVF的增量成本,对于不明原因不孕的夫妇来说是最高的(15000欧元至超过60000欧元),并且对他们来说,很大程度上取决于女性年龄和不孕持续时间,而对于子宫内膜异位症患者则是最低的(8000 - 23000欧元),对于这类患者,仅略微依赖于女性年龄和不孕持续时间。
一些国家有关于IVF适应症的指南,使用诊断类别、女性年龄和不孕持续时间。这些指南的CE尚不清楚,且证据基础仅存在于双侧输卵管阻塞方面,其他诊断类别则没有。
研究设计、规模、持续时间:采用建模方法,基于文献以及2002年1月至2003年12月在荷兰国家等候名单上登记的符合IVF或卵胞浆内单精子注射(ICSI)治疗条件的夫妇的前瞻性队列研究数据。
参与者/材料、设置、方法:共纳入5962对夫妇。根据等候名单观察结果估计自然持续妊娠的几率,根据开始治疗的原发性不孕夫妇的随访数据估计IVF后持续妊娠的几率。考虑的预后特征包括女性年龄、不孕持续时间和诊断类别。从社会角度评估IVF成本,并在具有代表性的患者样本中确定成本。对两种情况进行成本效益比较:(I)再等待一年,然后进行1年的IVF;(II)立即进行1年的IVF,并在次年尝试自然受孕。针对由预后因素确定的分层进行比较。最终结果是活产。
与推迟IVF相比,立即进行IVF方案的活产率增加随女性年龄增加而增加,且与诊断类别或不孕持续时间无关。相比之下,相应的成本增加主要取决于诊断类别和不孕持续时间。对于34岁及以上、不孕持续1年的子宫内膜异位症患者,最低CE比率略低于每活产儿10000欧元。对于30岁、不孕持续3年的不明原因不孕患者,最高CE比率达到每活产儿56000欧元,从32岁起降至每活产儿低于30000欧元。在34岁及以上、不孕持续3年时,该比率降至每活产儿低于20000欧元。其他三个诊断类别(即男性不育、激素性和免疫/宫颈性)的CE比率介于两者之间。
局限性、谨慎原因:我们应用了不包括冷冻胚胎的IVF几率估计值,因为我们没有相关数据。因此,我们不知道冷冻胚胎移植对CE的影响。
IVF变得具有成本效益的不孕持续时间,首先取决于社会为多一个活产儿支付的意愿水平,其次,在一定支付意愿水平下,取决于女性年龄和诊断类别。在当前指南中,在决定是否开始IVF治疗以及何时开始时,应始终考虑自然受孕的几率。
研究资金/利益冲突:由荷兰卫生研究与发展组织(ZonMW,资助号945 - 12 - 013)资助。ZonMW在研究设计、数据收集、数据分析与解释或报告撰写方面没有作用。利益冲突:无。